Ikena Oncology (IKNA) director Renaud received 13,419 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Ronald C Renaud JR (director at Ikena Oncology Inc., IKNA) reported that they received 13,419 Stock Option (Right to Buy) on Jun 9, 2022.
- Reporting person
- Renaud Ronald C JR
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 9, 2022 | Grant or award (A) | Stock Option (Right to Buy)On 13,419 Common Stock1 | +13,419 | - | - | 13,419 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 13,419 direct
Footnotes from the filing
- 1. This option shall vest in full upon the earlier of (i) June 9, 2023 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Renaud report in this IKNA Form 4?
Ronald C Renaud JR (director at Ikena Oncology Inc., IKNA) reported that they received 13,419 Stock Option (Right to Buy) on Jun 9, 2022.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for IKNA
Earlier insider filings at IKNA
- Jun 13, 2022SEC Form 4 filed by Formela Jean Francois
- Jun 13, 2022SEC Form 4 filed by Bonita David P
- Jun 13, 2022SEC Form 4 filed by Wooster Richard
- Jun 13, 2022SEC Form 4 filed by Koehler Maria
- Apr 25, 2022SEC Form 4 filed by Marango Jotin
Keep researching IKNA
- IKNA insider tradesEvery buy and sale reported by Ikena Oncology Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
Quantisnow market dataNASDAQ
IKNA
Ikena Oncology Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2021
Get push alerts for IKNA
Full IKNA profile on Quantisnow Follow IKNA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time